Gbemisola Allwell-Brown
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gbemisola Allwell-Brown has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Andreas Mårtensson
Department of Women’s and Children’s Health, International Maternal and Child Health (IMCH), Uppsala University , SE-751 85 Uppsala , Sweden
2 shared publicationsEmily White Johansson
Department of Women’s and Children’s Health, International Maternal and Child Health (IMCH), Uppsala University , SE-751 85 Uppsala , Sweden
2 shared publications- Freddy Eric Kitutu
Department of Pharmacy Kampala Central Region Makerere University School of Health Sciences
2 shared publications - Laith Hussain-Alkhateeb
School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, Gothenburg University, Box 469, 40530 Göteborg, Sweden
2 shared publications - Susanne Strömdahl
Uppsala University
2 shared publications - Andreas Mårtensson
Global Health and Migration Unit, Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden
1 shared publication
Latest Publications
- Open Access
- 5 September 2022
- Published by Oxford University Press (OUP) in JAC-Antimicrobial Resistance
- Vol. 4 (5) , dlac091
Patterns and contextual determinants of antibiotic prescribing for febrile under-five outpatients at primary and secondary healthcare facilities in Bugisu, Eastern Uganda
Objectives: To describe patterns and contextual determinants of antibiotic prescribing for febrile under-five outpatients at primary and secondary healthcare facilities across Bugisu, Eastern Uganda. Methods: We surveyed 37 public and private-not-for-profit healthcare facilities and conducted a retrospective review of antimicrobial prescribing patterns among febrile under-five outpatients (with a focus on antibiotics) in 2019–20, based on outpatient registers. Multilevel logistic regression analysis was used to identify determinants of antibiotic prescribing at patient- and healthcare facility-levels. Results: Antibiotics were prescribed for 62.2% of 3471 febrile under-five outpatients. There were a total of 2478 antibiotic prescriptions of 22 antibiotic types: amoxicillin (52.2%), co-trimoxazole (14.7%), metronidazole (6.9%), gentamicin (5.7%), ceftriaxone (5.3%), ampicillin/cloxacillin (3.6%), penicillin (3.1%), and others (8.6%). Acute upper respiratory tract infection (AURTI) was the commonest single indication for antibiotic prescribing, with 76.3% of children having AURTI as their only documented diagnosis receiving antibiotic prescriptions. Only 9.2% of children aged 2–59 months with non-severe pneumonia received antibiotic prescriptions in line with national guidelines. Higher health centre levels, and private-not-for-profit ownership (adjusted OR, 4.30; 95% CI, 1.91–9.72) were significant contextual determinants of antibiotic prescribing. Conclusions: We demonstrated a high antibiotic prescribing prevalence among febrile under-five outpatients in Bugisu, Eastern Uganda, including prescriptions for co-trimoxazole and ampicillin/cloxacillin (which are not indicated in the management of the common causes of under-five febrile illness in Uganda). Study findings may be linked to limited diagnostic capacity and inadequate antibiotic availability, which require prioritization in interventions aimed at improving rational antibiotic prescribing among febrile under-five outpatients.
- 5 September 2022
- Published by Oxford University Press (OUP) in JAC-Antimicrobial Resistance
- Vol. 4 (5) , dlac091
Open AccessPatterns and contextual determinants of antibiotic prescribing for febrile under-five outpatients at primary and secondary healthcare facilities in Bugisu, Eastern Uganda
Objectives: To describe patterns and contextual determinants of antibiotic prescribing for febrile under-five outpatients at primary and secondary healthcare facilities across Bugisu, Eastern Uganda. Methods: We surveyed 37 public and private-not-for-profit healthcare facilities and conducted a retrospective review of antimicrobial prescribing patterns among febrile under-five outpatients (with a focus on antibiotics) in 2019–20, based on outpatient registers. Multilevel logistic regression analysis was used to identify determinants of antibiotic prescribing at patient- and healthcare facility-levels. Results: Antibiotics were prescribed for 62.2% of 3471 febrile under-five outpatients. There were a total of 2478 antibiotic prescriptions of 22 antibiotic types: amoxicillin (52.2%), co-trimoxazole (14.7%), metronidazole (6.9%), gentamicin (5.7%), ceftriaxone (5.3%), ampicillin/cloxacillin (3.6%), penicillin (3.1%), and others (8.6%). Acute upper respiratory tract infection (AURTI) was the commonest single indication for antibiotic prescribing, with 76.3% of children having AURTI as their only documented diagnosis receiving antibiotic prescriptions. Only 9.2% of children aged 2–59 months with non-severe pneumonia received antibiotic prescriptions in line with national guidelines. Higher health centre levels, and private-not-for-profit ownership (adjusted OR, 4.30; 95% CI, 1.91–9.72) were significant contextual determinants of antibiotic prescribing. Conclusions: We demonstrated a high antibiotic prescribing prevalence among febrile under-five outpatients in Bugisu, Eastern Uganda, including prescriptions for co-trimoxazole and ampicillin/cloxacillin (which are not indicated in the management of the common causes of under-five febrile illness in Uganda). Study findings may be linked to limited diagnostic capacity and inadequate antibiotic availability, which require prioritization in interventions aimed at improving rational antibiotic prescribing among febrile under-five outpatients.
- Open Access
- 16 February 2022
- Published by Oxford University Press (OUP) in JAC-Antimicrobial Resistance
- Vol. 4 (Supplement)
P49 Determinants of trends in reported antibiotic use for sick children from LMICs (2005–17): analysis of 132 national surveys from 73 countries
Objectives: To analyse trends in reported antibiotic use for children aged <5 years with fever, diarrhoea or cough with fast or difficult breathing (outcome) from low- and middle-income countries (LMICs) during 2005–17, disaggregated by the following user characteristics: rural/urban residence, maternal education, household wealth and healthcare source visited. Methods: Based on 132 Demographic and Health Surveys and Multiple Indicator Cluster Surveys from 73 LMICs, the outcome, disaggregated by user characteristics for all country-years was estimated using a hierarchical Bayesian linear regression model. Results: Across LMICs during 2005–17, the greatest relative increases in the outcome occurred in rural areas, poorest quintiles and least educated populations, particularly in low-income countries and South-East Asia. In low-income countries, rural areas had a 72% relative increase from 17.8% [uncertainty interval (UI): 5.2%–44.9%] in 2005 to 30.6% (11.7%–62.1%) in 2017, compared with a 29% relative increase in urban areas from 27.1% (8.7%–58.2%) in 2005 to 34.9% (13.3%–67.3%) in 2017. Despite these increases, the outcome was consistently highest in urban areas, wealthiest quintiles, and populations with the highest maternal education. Conclusions: These estimates suggest that the increasing reported antibiotic use for sick children aged <5 years in LMICs during 2005–17 was driven by gains among groups often underserved by formal health services.
- 16 February 2022
- Published by Oxford University Press (OUP) in JAC-Antimicrobial Resistance
- Vol. 4 (Supplement)
Open AccessP49 Determinants of trends in reported antibiotic use for sick children from LMICs (2005–17): analysis of 132 national surveys from 73 countries
Objectives: To analyse trends in reported antibiotic use for children aged <5 years with fever, diarrhoea or cough with fast or difficult breathing (outcome) from low- and middle-income countries (LMICs) during 2005–17, disaggregated by the following user characteristics: rural/urban residence, maternal education, household wealth and healthcare source visited. Methods: Based on 132 Demographic and Health Surveys and Multiple Indicator Cluster Surveys from 73 LMICs, the outcome, disaggregated by user characteristics for all country-years was estimated using a hierarchical Bayesian linear regression model. Results: Across LMICs during 2005–17, the greatest relative increases in the outcome occurred in rural areas, poorest quintiles and least educated populations, particularly in low-income countries and South-East Asia. In low-income countries, rural areas had a 72% relative increase from 17.8% [uncertainty interval (UI): 5.2%–44.9%] in 2005 to 30.6% (11.7%–62.1%) in 2017, compared with a 29% relative increase in urban areas from 27.1% (8.7%–58.2%) in 2005 to 34.9% (13.3%–67.3%) in 2017. Despite these increases, the outcome was consistently highest in urban areas, wealthiest quintiles, and populations with the highest maternal education. Conclusions: These estimates suggest that the increasing reported antibiotic use for sick children aged <5 years in LMICs during 2005–17 was driven by gains among groups often underserved by formal health services.
- Open Access
- 1 July 2021
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 108, 473-482
Determinants of trends in reported antibiotic use among sick children under five years of age across low-income and middle-income countries in 2005–17: A systematic analysis of user characteristics based on 132 national surveys from 73 countries
- 1 July 2021
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 108, 473-482
Open AccessDeterminants of trends in reported antibiotic use among sick children under five years of age across low-income and middle-income countries in 2005–17: A systematic analysis of user characteristics based on 132 national surveys from 73 countries